| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2016NatCo...711312K |
| P356 | DOI | 10.1038/NCOMMS11312 |
| P932 | PMC publication ID | 4853428 |
| P698 | PubMed publication ID | 27115988 |
| P5875 | ResearchGate publication ID | 301671080 |
| P50 | author | V. Wee Yong | Q56101901 |
| Marcus W Koch | Q58460928 | ||
| Khalil S Rawji | Q87362635 | ||
| Jason R Plemel | Q39420528 | ||
| P2093 | author name string | Ping Zhang | |
| Chang-Chun Ling | |||
| Michael B Keough | |||
| James A Rogers | |||
| Tieyu Chen | |||
| Erin L Stephenson | |||
| Samuel K Jensen | |||
| Lorraine W Lau | |||
| Mitchel G Hurlbert | |||
| P2860 | cites work | Inhibition of CNS remyelination by the presence of semaphorin 3A. | Q54383932 |
| LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis | Q57186801 | ||
| Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? | Q64461677 | ||
| Astrocytes promote process outgrowth by adult human oligodendrocytes in vitro through interaction between bFGF and astrocyte extracellular matrix | Q71612409 | ||
| Vulnerability of human neurons to T cell-mediated cytotoxicity | Q73552887 | ||
| N-Acetylglucosamine Inhibits T-helper 1 (Th1)/T-helper 17 (Th17) Cell Responses and Treats Experimental Autoimmune Encephalomyelitis | Q22248070 | ||
| Remyelination therapy for multiple sclerosis | Q26824246 | ||
| Regeneration beyond the glial scar | Q28239915 | ||
| Modulation of the proteoglycan receptor PTPσ promotes recovery after spinal cord injury | Q28253162 | ||
| Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation | Q28290361 | ||
| Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS | Q28589814 | ||
| Remyelination protects axons from demyelination-associated axon degeneration | Q29302305 | ||
| Chondroitinase ABC promotes functional recovery after spinal cord injury | Q29615017 | ||
| Skin-homing receptors on effector leukocytes are differentially sensitive to glyco-metabolic antagonism in allergic contact dermatitis | Q33606887 | ||
| PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration | Q33610127 | ||
| Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2 | Q33953332 | ||
| Oligodendroglia metabolically support axons and contribute to neurodegeneration. | Q34032818 | ||
| The inhibitory effects of chondroitin sulfate proteoglycans on oligodendrocytes | Q34208617 | ||
| Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain | Q34341627 | ||
| A regenerative approach to the treatment of multiple sclerosis | Q34376469 | ||
| Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. | Q34441121 | ||
| Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo | Q34472745 | ||
| Remyelination can be extensive in multiple sclerosis despite a long disease course | Q34578773 | ||
| Protocol to isolate a large amount of functional oligodendrocyte precursor cells from the cerebral cortex of adult mice and humans | Q35058625 | ||
| Peracetylated 4-fluoro-glucosamine reduces the content and repertoire of N- and O-glycans without direct incorporation. | Q35065252 | ||
| Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin. | Q35461070 | ||
| Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. | Q36501925 | ||
| Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. | Q36793938 | ||
| Rejuvenation of regeneration in the aging central nervous system | Q37023170 | ||
| Alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice | Q37249700 | ||
| Regulation of heparan sulfate and chondroitin sulfate glycosaminoglycan biosynthesis by 4-fluoro-glucosamine in murine airway smooth muscle cells | Q37285056 | ||
| Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling | Q37347920 | ||
| Enhancing remyelination in disease--can we wrap it up? | Q37867334 | ||
| Combination treatment with chondroitinase ABC in spinal cord injury--breaking the barrier | Q38120433 | ||
| Pathophysiology of the brain extracellular matrix: a new target for remyelination. | Q38132334 | ||
| Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation | Q38362396 | ||
| Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. | Q38524950 | ||
| Derivation of enriched oligodendrocyte cultures and oligodendrocyte/neuron myelinating co-cultures from post-natal murine tissues. | Q39149972 | ||
| Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination. | Q39266450 | ||
| Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity | Q39492965 | ||
| Inhibiting glycosaminoglycan chain polymerization decreases the inhibitory activity of astrocyte-derived chondroitin sulfate proteoglycans | Q40030617 | ||
| Remyelination is extensive in a subset of multiple sclerosis patients. | Q40295868 | ||
| Versican V1 isoform induces neuronal differentiation and promotes neurite outgrowth | Q40831376 | ||
| An in vitro model of reactive astrogliosis and its effect on neuronal growth. | Q41952761 | ||
| White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis | Q43838103 | ||
| Additive effect of the combination of glatiramer acetate and minocycline in a model of MS. | Q45180838 | ||
| Remyelination capacity of the MS brain decreases with disease chronicity | Q45353313 | ||
| Screening for inhibitors of microglia to reduce neuroinflammation | Q46213310 | ||
| Localization of chondroitin sulfate proteoglycan versican in adult brain with special reference to large projection neurons | Q46307798 | ||
| Overcoming neurite-inhibitory chondroitin sulfate proteoglycans in the astrocyte matrix. | Q48098141 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 11312 | |
| P577 | publication date | 2016-04-26 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination | |
| P478 | volume | 7 |
| Q40104988 | 2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination. |
| Q92370548 | 2-arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditions |
| Q49336399 | A Therapeutic Link between Astrogliosis and Remyelination in a Mouse Model of Multiple Sclerosis. |
| Q61806575 | Acute and chronic demyelinated CNS lesions exhibit opposite elastic properties |
| Q92131927 | Astrocytes and Microglia as Major Players of Myelin Production in Normal and Pathological Conditions |
| Q39146141 | Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis. |
| Q64093586 | Biomimicking Fiber Scaffold as an Effective In Vitro and In Vivo MicroRNA Screening Platform for Directing Tissue Regeneration |
| Q91112091 | Cell-matrix tension contributes to hypoxia in astrocyte-seeded viscoelastic hydrogels composed of collagen and hyaluronan |
| Q52673695 | Chondroitin sulfate proteoglycans as novel drivers of leucocyte infiltration in multiple sclerosis. |
| Q89531782 | Chondroitin sulfate synthase 1 enhances proliferation of glioblastoma by modulating PDGFRA stability |
| Q55223367 | DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling. |
| Q47970704 | Deficiency of TREK-1 potassium channel exacerbates secondary injury following spinal cord injury in mice |
| Q55262746 | Detection of Glycan Shedding in the Blood: New Class of Multiple Sclerosis Biomarkers? |
| Q48020080 | Determinants of Axon Growth, Plasticity, and Regeneration in the Context of Spinal Cord Injury. |
| Q49644698 | Diverse functions of protein tyrosine phosphatase σ in the nervous and immune systems. |
| Q46448356 | Fibrinogen Activates BMP Signaling in Oligodendrocyte Progenitor Cells and Inhibits Remyelination after Vascular Damage. |
| Q83232034 | Identification of compounds that rescue otic and myelination defects in the zebrafish adgrg6 (gpr126) mutant |
| Q92806880 | Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination |
| Q96222241 | Mature oligodendrocytes bordering lesions limit demyelination and favor myelin repair via heparan sulphate production |
| Q48001723 | Mechanisms of lysophosphatidylcholine-induced demyelination: A primary lipid disrupting myelinopathy |
| Q57295496 | Modulation of proteoglycan receptor PTPσ enhances MMP-2 activity to promote recovery from multiple sclerosis |
| Q38718081 | Myelin regulatory factor drives remyelination in multiple sclerosis |
| Q89235953 | Neurodegenerative diseases: Laying the groundwork for remyelination |
| Q89586468 | Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system |
| Q92625022 | Niche stiffness underlies the ageing of central nervous system progenitor cells |
| Q52646465 | Perturbing chondroitin sulfate proteoglycan signaling through LAR and PTPσ receptors promotes a beneficial inflammatory response following spinal cord injury. |
| Q90618604 | Progressive multiple sclerosis: latest therapeutic developments and future directions |
| Q47155362 | Protamine neutralizes chondroitin sulfate proteoglycan-mediated inhibition of oligodendrocyte differentiation |
| Q93214599 | Reactive astrocytes in multiple sclerosis impair neuronal outgrowth through TRPM7-mediated chondroitin sulfate proteoglycan production |
| Q49986398 | Regenerating CNS myelin - from mechanisms to experimental medicines. |
| Q26744475 | Regenerative Capacity of Macrophages for Remyelination |
| Q64105817 | Regulation of Myelination by Exosome Associated Retinoic Acid Release from NG2-Positive Cells |
| Q89660155 | Regulation of Oligodendrocyte Functions: Targeting Lipid Metabolism and Extracellular Matrix for Myelin Repair |
| Q90127299 | Regulation of autophagy by inhibitory CSPG interactions with receptor PTPσ and its impact on plasticity and regeneration after spinal cord injury |
| Q39420410 | Remyelination therapies: a new direction and challenge in multiple sclerosis |
| Q47200107 | Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis |
| Q47134235 | Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic. |
| Q92565165 | Targeting the Chondroitin Sulfate Proteoglycans: Evaluating Fluorinated Glucosamines and Xylosides in Screens Pertinent to Multiple Sclerosis |
| Q52669755 | The Biology of Regeneration Failure and Success After Spinal Cord Injury. |
| Q88757808 | The Effects of Normal Aging on Regional Accumulation of Hyaluronan and Chondroitin Sulfate Proteoglycans in the Mouse Brain |
| Q55097614 | The Extracellular Matrix and Remyelination Strategies in Multiple Sclerosis. |
| Q91152885 | The PTN-PTPRZ signal activates the AFAP1L2-dependent PI3K-AKT pathway for oligodendrocyte differentiation: Targeted inactivation of PTPRZ activity in mice |
| Q92384464 | The benefits of neuroinflammation for the repair of the injured central nervous system |
| Q88230827 | The extracellular matrix: Focus on oligodendrocyte biology and targeting CSPGs for remyelination therapies |
| Q92745530 | The fate and function of oligodendrocyte progenitor cells after traumatic spinal cord injury |
| Q92300904 | Transforming growth factor-beta renders ageing microglia inhibitory to oligodendrocyte generation by CNS progenitors |
| Q48132838 | Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease? |
Search more.